Stay updated on PANAMO IFX-1 Clinical Trial
Sign up to get notified when there's something new on the PANAMO IFX-1 Clinical Trial page.

Latest updates to the PANAMO IFX-1 Clinical Trial page
- Check7 days agoChange DetectedA new Revision: v3.3.3 is shown, and the HHS Vulnerability Disclosure link along with Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedA note was added clarifying that publications are automatically filled from PubMed and may not all pertain to the study. The previous PubMed-origin wording and the old revision label were removed.SummaryDifference0.1%

- Check43 days agoChange DetectedRemoved the notice about potential delays due to funding and where to check NIH operating status. The update removes administrative status information but does not alter trial data, eligibility criteria, or study results on the page.SummaryDifference0.3%

- Check57 days agoChange DetectedThe screenshots show no changes to core content such as study title, conditions, eligibility criteria, primary or secondary outcomes, or location details; only minor layout and styling differences. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check86 days agoChange DetectedCore content updated with a funding-operational status notice and a version bump to v3.2.0; removed the old v3.1.0 reference.SummaryDifference3%

- Check93 days agoChange Detected- Removed several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and - added a new Revision: v3.1.0.SummaryDifference0.4%

Stay in the know with updates to PANAMO IFX-1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PANAMO IFX-1 Clinical Trial page.